FDA approves gene therapies for sickle cell disease, a 'functional cure' for many

The FDA has approved two new gene therapies for sickle cell disease, a 'functional cure' for many patients

Related Keywords

New York ,United States ,American ,Americans ,Haydar Frangoul ,Jimi Olaghere ,Jonathan Lubin ,Peter Marks ,Presbyterian Columbia University Irving Medical Center ,Treatment Center At Mass ,Centers For Disease ,Drug Administration ,Sarah Cannon Research Institute In Nashville ,Vertex Pharmaceuticals ,Black Americans ,Disease Control ,Sharl Azar ,Medical Director ,Comprehensive Sickle Cell Disease ,Treatment Center ,Mass General ,Biologics Evaluation ,Joe Biden ,African American ,Sarah Cannon Research Institute ,Hospital At Tristar ,Nobel Prize ,Bluebird Bio ,Columbia University Irving Medical Center ,